Zobrazeno 1 - 10
of 45
pro vyhledávání: '"H A Boushey"'
Autor:
Y Wang, C Tong, Z Wang, D Mauger, K G Tantisira, E Israel, S J Szefler, V M Chinchilli, H A Boushey, S C Lazarus, R F Lemanske, R Wu
Publikováno v:
Wang, Y; Tong, C; Wang, Z; Wang, Z; Mauger, D; Tantisira, KG; et al.(2015). Pharmacodynamic genome-wide association study identifies new responsive loci for glucocorticoid intervention in asthma. Pharmacogenomics Journal. doi: 10.1038/tpj.2014.83. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/44r1f8tr
The pharmacogenomics journal, vol 15, iss 5
The pharmacogenomics journal, vol 15, iss 5
© 2015 Macmillan Publishers Limited Asthma is a chronic lung disease that has a high prevalence. The therapeutic intervention of this disease can be made more effective if genetic variability in patients’ response to medications is implemented. Ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::113b0c50a5272709d37d0e5c30328db5
https://europepmc.org/articles/PMC6156797/
https://europepmc.org/articles/PMC6156797/
Autor:
M. E. Lachowicz-Scroggins, W. E. Finkbeiner, E. D. Gordon, S. Yuan, L. Zlock, N. R. Bhakta, P. G. Woodruff, J. V. Fahy, H. A. Boushey
Publikováno v:
Clinical & Experimental Allergy. 47:i-i
Autor:
R F, Lemanske, C A, Sorkness, E A, Mauger, S C, Lazarus, H A, Boushey, J V, Fahy, J M, Drazen, V M, Chinchilli, T, Craig, J E, Fish, J G, Ford, E, Israel, M, Kraft, R J, Martin, S A, Nachman, S P, Peters, J D, Spahn, S J, Szefler
Publikováno v:
JAMA. 285(20)
Inhaled long-acting beta(2)-agonists improve asthma control when added to inhaled corticosteroid (ICS) therapy.To determine whether ICS therapy can be reduced or eliminated in patients with persistent asthma after adding a long-acting beta(2)-agonist
Autor:
S C, Lazarus, H A, Boushey, J V, Fahy, V M, Chinchilli, R F, Lemanske, C A, Sorkness, M, Kraft, J E, Fish, S P, Peters, T, Craig, J M, Drazen, J G, Ford, E, Israel, R J, Martin, E A, Mauger, S A, Nachman, J D, Spahn, S J, Szefler
Publikováno v:
JAMA. 285(20)
Long-acting beta(2)-agonists are prescribed for patients with persistent asthma and are sometimes used without inhaled corticosteroids (ICSs). No evidence exists, however, to support their use as monotherapy in adults with persistent asthma.To examin
Autor:
E, Israel, J M, Drazen, S B, Liggett, H A, Boushey, R M, Cherniack, V M, Chinchilli, D M, Cooper, J V, Fahy, J E, Fish, J G, Ford, M, Kraft, S, Kunselman, S C, Lazarus, R F, Lemanske, R J, Martin, D E, McLean, S P, Peters, E K, Silverman, C A, Sorkness, S J, Szefler, S T, Weiss, C N, Yandava
Publikováno v:
International archives of allergy and immunology. 124(1-3)
Regular use of inhaled beta-adrenergic agonists may have adverse effects in some asthma patients. Polymorphisms of the beta(2)-adrenergic receptor (beta(2)-AR) can affect its regulation; however, results of smaller studies of the effects of such poly
Publikováno v:
Chest. 117(4)
To determine if African-American and white patients with asthma (1) differ in the words they use to describe their breathlessness, and (2) differ in their perception of breathlessness.Descriptive cross-sectional design.The study setting was located i
Autor:
J E, Fish, S P, Peters, C V, Chambers, S J, McGeady, K R, Epstein, H A, Boushey, R M, Cherniack, V M, Chinchilli, J M, Drazen, J V, Fahy, S S, Hurd, E, Israel, S C, Lazarus, R F, Lemanske, R J, Martin, E A, Mauger, C, Sorkness, S J, Szefler
Publikováno v:
American journal of respiratory and critical care medicine. 156(4 Pt 1)
Colchicine demonstrates an array of anti-inflammatory properties of potential relevance to asthma. However, the efficacy of colchicine as an alternative to inhaled corticosteroid therapy for asthma is unknown. Five centers participated in a controlle
Controversies involving inhaled beta-agonists and inhaled corticosteroids in the treatment of asthma
Autor:
J V, Fahy, H A, Boushey
Publikováno v:
Clinics in chest medicine. 16(4)
Controversy over the use of inhaled beta-agonists has dated almost from their introduction as a treatment for asthma. Their effectiveness as bronchodilators is not disputed, but there is concern that they may worsen asthma control if used regularly a
Publikováno v:
Journal of investigative medicine : the official publication of the American Federation for Clinical Research. 43(4)
Metal fume fever is a flu-like illness caused by zinc oxide fume inhalation and mediated by unknown mechanisms. It is one of a group of work-related febrile inhalational syndromes. We studied bronchoalveolar lavage (BAL) obtained from cigarette smoki
Autor:
A, Dudley, H A, Boushey
Publikováno v:
Annals of the Academy of Medicine, Singapore. 24(3)